Small and mid-sized Indian pharmaceutical firms are witnessing a shift in orders away from China. As Western buyers diversify their supply ...

September saw a decline in demat account openings, falling to 2.89 million, which is an 11.5% reduction compared to the previous month. Nev...

The SME Growth Fund aims to provide long-term growth capital and address financing gaps for these businesses. By targeting manufacturing an...

Three SME IPOs — Pind Hospitality, Acme Universal Safezone 9 and Shivchem Agro — made their debut on the BSE SME platform on October 6. Tog...

Indian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...

Four SME IPOs, including Bench Mark Infotech Services, Himalayan Solar, Dudani Retail, and Sai Urja Indo Ventures, will list on the BSE and...

Paramount Syntex's Rs 82-crore IPO was subscribed 1.35 times on the second day of bidding on the BSE SME platform. The issue received bids ...

The momentum had picked up sharply from August, after a muted first four months of FY27, as stronger listing gains and steady liquidity pul...

In September, foreign portfolio investors shed a staggering Rs 35,860 crore from Indian equities, driven by global uncertainties and rising...

Sebi has provided observations for the IPOs of Carlsberg India, Matangi Rubber, Ujin Pharma, and TMC Transformer. Carlsberg's filing is und...

The initial public offering (IPO) will open for subscription on September 30 and conclude on October 5. The shares will be listed on the BS...

Indian corporations are making bold strides abroad, with Essar establishing a massive $15 billion steel complex in Iowa. Notable companies ...

On September 30, investors will witness the debut of five small and medium-sized enterprise IPOs, including Coreintegra Consulting and Pooj...

Eight SME IPOs — TNA Solutions, Omara Ventures India, Sollfege Smart Electronics, Eventions, Acme India Industries, Paramount Syntex, SJP U...

Sun Pharma is planning to raise about Rs 10,000 crore through rupee-denominated bonds to partly refinance a bridge loan used for its Organo...

Indian pharma stocks, including Sun Pharma and Aurobindo Pharma, are in focus after the US exempted India and 19 other countries from 100% ...

HRV Pharma CEO Hari Kiran Chereddi says investing in capacity at partner facilities, exploring acquisitions for market access; forecasts Rs...